참고문헌
- Abu-Amero KK, Alzahrani AS, Zou M, Shi Y. (2005). High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines. Oncogene, 24, 1455-60. https://doi.org/10.1038/sj.onc.1208292
- Allalunis-Turner J, Ma I, Hanson J, Pearcey RG. (2006). mtDNA mutations in invasive cervix tumors: a retrospective analysis. Cancer lett, 243, 193-201. https://doi.org/10.1016/j.canlet.2005.11.035
- Anderson S, Bankier AT, Barrell BG, et al. (1981). Sequence and organization of the human mitochondrial genome. Nature, 290, 457-65. https://doi.org/10.1038/290457a0
- Bai Y, Attardi G. (1998). The mtDNA-encoded ND6 subunit of mitochondrial NADH dehydrogenase is essential for the assembly of the membrane arm and the respiratory function of the enzyme. EMBO J, 17, 4848-58. https://doi.org/10.1093/emboj/17.16.4848
- Brandon M, Baldi P, Wallace DC. (2006). Mitochondrial mutations in cancer. Oncogene, 25, 4647-62. https://doi.org/10.1038/sj.onc.1209607
- Canter JA, Kallianpur AR, Parl FF, Millikan RC. (2005). Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res, 65, 8028-33.
- Chatterjee A, Mambo E, Sidransky D. (2006). Mitochondrial DNA mutations in human cancer. Oncogene, 25, 4663-74. https://doi.org/10.1038/sj.onc.1209604
- DiMauro S, Schon EA. (2003). Mitochondrial respiratory-chain diseases. N Eng J Med, 348,2656-68. https://doi.org/10.1056/NEJMra022567
- Fogg VC, Lanning NJ, Mackeigan JP. (2011). Mitochondria in cancer: at the crossroads of life and death. Chin J Cancer, 30, 526-39. https://doi.org/10.5732/cjc.011.10018
- Gaude E, Frezza C. (2014). Defects in mitochondrial metabolism and cancer. Cancer Met, 2, 10. https://doi.org/10.1186/2049-3002-2-10
- Herrmann PC, Gillespie JW, Charboneau L, et al. (2003). Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer. Proteomics, 3, 1801-10. https://doi.org/10.1002/pmic.200300461
- Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. (1990). A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Gen, 46, 428-33.
- Huai JP, Ding J, Ye XH, Chen YP. (2014). Inflammatory bowel disease and risk of cholangiocarcinoma: evidence from a meta-analysis of population-based studies. Asian Pac J Cancer Prev, 15, 3477-82. https://doi.org/10.7314/APJCP.2014.15.8.3477
- Hung WY, Wu CW, Yin PH, et al. (2010). Somatic mutations in mitochondrial genome and their potential roles in the progression of human gastric cancer. Biochi Biophys Acta, 1800, 264-70. https://doi.org/10.1016/j.bbagen.2009.06.006
- Khunluck T, Kukongviriyapan V, Puapairoj A, et al (2014). Association of NRF2 polymorphism with cholangiocarcinoma prognosis in Thai patients. Asian Pac J Cancer Prev, 15, 299-304. https://doi.org/10.7314/APJCP.2014.15.1.299
- Kim R, Emi M, Tanabe K. (2006). Role of mitochondria as the gardens of cell death. Cancer Chemo Pharmacol, 57, 545-53. https://doi.org/10.1007/s00280-005-0111-7
- Krieg RC, Knuechel R, Schiffmann E, et al. (2004). Mitochondrial proteome: cancer-altered metabolism associated with cytochrome c oxidase subunit level variation. Proteomics, 4, 2789-95. https://doi.org/10.1002/pmic.200300796
- Liu VW, Shi HH, Cheung AN, et al. (2001). High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res, 61, 5998-6001.
- Liu VW, Yang HJ, Wang Y, et al. (2003). High frequency of mitochondrial genome instability in human endometrial carcinomas. Brit J Cancer, 89, 697-701. https://doi.org/10.1038/sj.bjc.6601110
- Ma Y, Bai RK, Trieu R, Wong LJ. (2010). Mitochondrial dysfunction in human breast cancer cells and their
피인용 문헌
- Functional and genetic deconstruction of the cellular origin in liver cancer vol.15, pp.11, 2015, https://doi.org/10.1038/nrc4017
- High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma vol.37, pp.10, 2016, https://doi.org/10.1007/s13277-016-5204-x